Kendra Congdon

Kendra Congdon has a long history of work experience in the field of preclinical translation. Kendra began their career in 2000 as a Research Technician at Duke University. Kendra then became a Postdoctoral Researcher at Duke University in 2008. From 2009 to 2020, they were an Assistant Professor and Research Scholar at Duke University, where they were responsible for the scientific portfolio of an NIH grant-funded program focused on the translation of immunotherapeutic treatments for brain tumors. In 2020, they joined Tune Therapeutics as the Director of Preclinical Translation and later became the Associate Director of Preclinical Translation.

Kendra Congdon attended Duke University from 1995 to 1999, where they earned a Bachelor of Science in Biology with a Concentration in Genetics. Kendra then went on to attend Duke University Graduate School from 2002 to 2008, where they earned a Doctor of Philosophy in Molecular Cancer Biology.